替卡格雷洛

[CAS號 ] 274693-27-5
[分子式] C23H28F2N6O4S
[分子量] 321.32
[含量] 99％
[外觀]白色或無色結晶性粉末
關於替卡格雷
Ticagrelor is a platelet aggregation inhibitor.替卡格雷是血小板聚集抑製劑。 It works by slowing or stopping platelets from sticking to blood vessel walls or injured tissues.它通過減慢或阻止血小板粘附在血管壁或受傷的組織上而起作用。
Ticagrelor is a platelet aggregation inhibitor.Ticagrelor was approved for use in the European Union by the European Commission on December 3, 2010.Ticagrelor was approved by the US Food and Drug Administration on July 20, 2011. Ticagrelor is an antagonist of the P2Y12 receptor.替卡格雷洛是一种血小板聚集抑製劑。替卡格雷洛於XNUMX年XNUMX月XNUMX日獲得歐盟委員會批准在歐盟使用。替卡格雷洛於XNUMX年XNUMX月XNUMX日獲得美國食品和藥物管理局批准。替卡格雷洛是PXNUMXYXNUMX受體的拮抗劑。 。 Ticagrelor is indicated for the prevention of thrombotic events in people with acute coronary syndrome or myocardial infarction with ST elevation.替卡格雷用於在急性冠狀動脈綜合徵或ST抬高的心肌梗死患者中預防血栓形成事件。